LIVE MARKETS-Some blurred lines, but growth vs value eyes record highs

Reuters
16 May
LIVE MARKETS-Some blurred lines, but growth vs value eyes record highs

US equity index futures green: Russell 2000 up ~0.6%

Apr housing starts, building permits < estimates

Apr import, export prices > estimates

Euro STOXX 600 index up ~0.2%

Dollar edges up; bitcoin, crude rise; gold down ~2%

US 10-Year Treasury yield falls to ~4.40%

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SOME BLURRED LINES, BUT GROWTH VS VALUE EYES RECORD HIGHS

There have been eye-popping swings this year, which now have traders seeing double. Indeed, the S&P 500 index .SPX tumbled 19% from its mid-February record close to its early-April closing low.

And now, since that low, the SPX has rocketed. In fact, it's now risen 19% into its close on Thursday. With this, the benchmark index is now up 0.6% YTD, and down just 3.7% from its record close.

Meanwhile, the perennial battle between growth and value has also been volatile. That said, with growth's QTD surge, it's now on track to outperform value for a third-straight year.

Indeed, after collapsing 11% from its early-January high into its early-April trough, the S&P 500 growth .IGX/S&P 500 value .IVX ratio, has now bounced back just over 12%.

On Wednesday, the ratio closed at its highest level since December 2021. The ratio is now up 2.3% YTD, and only down about 2.5% from its November 2021 record close:

Meanwhile, in early May, the ratio's 50-day moving average $(DMA)$ nearly crossed below the 200-DMA. However, the 50-day has since turned higher again.

Of note, since May 2023, the ratio's 50-DMA has seen only one minor closing violation of the 200-DMA (in early February 2024). Thus, despite the ratio's numerous gyrations over the past two years or so, the trend of growth outperforming value has persisted.

A ratio push to challenge the resistance line from its 2000 peak would see growth makes new highs vs value.

Growth can thank renewed strength in Mag 7 names .MAG, tech .SPLRCT, and chips .SOX for its resurgence.

Since the April 8 close, MAG is up 29%, tech is up 31%, and chips have surged 38%.

As of the end of April, all seven Mag 7 stocks were among the top 10 holdings in the SPDR S&P 500 growth ETF SPYG.P, accounting for 43% of its exposure. With this, tech and tech-adjacent names held a 57% overall weight in the SPYG.

Against this, there were three Mag 7 stocks in the SPDR S&P 500 value ETF's SPYV.P top 10 holdings, at about a 17% weight in total. Tech, and tech adjacent names, at 26.4%, were also the largest weight in the SPYV, but still much less than in the SPYG.

However, healthcare .SPXHC, at around 16%, was the SPYV's second biggest exposure. Healthcare is down 2% since the April 8 close, and is the second worst performing sector YTD.

(Terence Gabriel)

*****

FRIDAY'S OTHER LIVE MARKETS POSTS:

SCOPE FOR EUROPE'S BANKS TO UPGRADE GUIDANCE CLICK HERE

EUROPEAN CONSUMER STAPLES' H2 RECOVERY HOPES "MAY PROVE OPTIMISTIC" - MS CLICK HERE

LESSONS FROM APRIL'S TARIFF TURMOIL CLICK HERE

EUROPE IN THE GREEN, SET FOR FIFTH WEEKLY RISE CLICK HERE

EUROPE BEFORE THE BELL: STOCKS SET TO ROUND OFF POSITIVE WEEK IN THE GREEN CLICK HERE

TRADE-DRIVEN RALLY ENDS THE WEEK WITH A WHIMPER CLICK HERE

GrowthvsValue05162025 https://tmsnrt.rs/4dEGi7D

(Terence Gabriel is a Reuters market analyst. The views expressed are his own)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10